- Medical cannabis, offering therapeutic potential for a wide range of conditions such as chronic pain, epilepsy, and anxiety, is becoming an increasingly vital component of Thailand’s evolving healthcare and wellness ecosystem, particularly in both clinical and alternative medicine settings due to its expanding regulatory support and integration into traditional Thai medicine
- The escalating demand for medical cannabis in Thailand is primarily driven by progressive legalization, growing public and professional awareness of its health benefits, and the development of a regulated distribution framework
- Bangkok dominated the Thailand medical cannabis market with the largest revenue share of 34.6% in 2024, attributed to its high concentration of licensed dispensaries, specialized hospitals, and research universities actively participating in cannabis-based clinical research. The capital city’s robust healthcare infrastructure and government-supported pilot clinics have significantly driven prescription volumes and patient access to high-grade medical cannabis
- Chiang Mai is expected to be the fastest-growing province in the Thailand medical cannabis market during the forecast period, with a projected CAGR of 16.8% from 2025 to 2032, fueled by increasing government support for cannabis cultivation, growth in wellness tourism, and regional emphasis on integrating cannabis with traditional herbal medicine. Chiang Mai’s emergence as a northern hub for cannabis education, certified farms, and practitioner training is driving rapid adoption and market expansion
- The Oil segment dominated the Thailand Medical Cannabis market with a market share of 28.5% in 2024, driven by its ease of use, precise dosing, and wide applicability in treating chronic conditions such as anxiety, epilepsy, and pain
